Dr. Fitzgibbons is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
520 Country Club Pkwy
Eugene, OR 97401Phone+1 541-683-5001Fax+1 541-683-1422- Is this information wrong?
Education & Training
Oregon Health & Science UniversityResidency, Internal Medicine, 1976 - 1977- Oregon Health & Science UniversityFellowship, Hematology and Medical Oncology, 1973 - 1976
- Oregon Health Science University HospitalInternship, Transitional Year, 1972 - 1973
University of Toronto Faculty of MedicineClass of 1972
Certifications & Licensure
OR State Medical License 1973 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 120 citationsRandomized Phase II Trial of Single-Agent Amrubicin or Topotecan as Second-Line Treatment in Patients With Small-Cell Lung Cancer Sensitive to First-Line Platinum-Base...Robert M. Jotte, Paul Conkling, Craig W. Reynolds, Matthew D. Galsky, Leonard Klein, James F. Fitzgibbons, R. McNally, Markus F. Renschler, Jennifer Wright Oliver> ;Journal of Clinical Oncology. 2011 Jan 20
- Results of a randomized phase II trial of amrubicin (AMR) versus topotecan (Topo) in patients with extensive-disease small cell lung cancer (ED-SCLC) sensitive to firs...Jotte R, Conkling P, Reynolds C, Klein L, Fitzgibbons JF, McNally R, Renschler M, Oliver JW> ;J. Clin. Oncol.. 2009-05-20
Professional Memberships
- Member
Hospital Affiliations
- McKenzie-Willamette Medical CenterSpringfield, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
